-transparent.png){kind=logo}
Eighty-three patients with rapidly progressing breast cancer (RPBC) were entered into a study of primary chemotherapy (cyclophosphamide, methotrexate, and 5-fluorouracil) and subsequent randomization to surgery or radiotherapy for control of local/regional disease. Eighty-three of these patients with redness, warmth, and edema compatible with clinical "inflammatory breast cancer" served as the focus for our analysis of factors associated with improved survival. The stage-specific disease-free intervals (DFI) of 36 and 21 months were substantially longer than in the earlier series (26 and 16 months) from the same institution. The evaluation of individual prognostic indicators revealed that the initial tumor size and the initial response to chemotherapy were the two independent factors most important in predicting the DFI. The continuing unmaintained 1-year remission in at least 12 patients supports the rationale for aggressive therapy in RPBC or "inflammatory breast cancer."
N Mourali, and
F Tabbane, and
L R Muenz, and
J Behi, and
F Ben Moussa, and
M Jaziri, and
P H Levine
December 1987,
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology,
N Mourali, and
F Tabbane, and
L R Muenz, and
J Behi, and
F Ben Moussa, and
M Jaziri, and
P H Levine
April 1989,
American journal of clinical oncology,
N Mourali, and
F Tabbane, and
L R Muenz, and
J Behi, and
F Ben Moussa, and
M Jaziri, and
P H Levine
December 2021,
Journal of surgical oncology,
N Mourali, and
F Tabbane, and
L R Muenz, and
J Behi, and
F Ben Moussa, and
M Jaziri, and
P H Levine
July 2005,
Journal of the Medical Association of Thailand = Chotmaihet thangphaet,
N Mourali, and
F Tabbane, and
L R Muenz, and
J Behi, and
F Ben Moussa, and
M Jaziri, and
P H Levine
May 1953,
The Journal of the Kentucky State Medical Association,
N Mourali, and
F Tabbane, and
L R Muenz, and
J Behi, and
F Ben Moussa, and
M Jaziri, and
P H Levine
February 1977,
The British journal of surgery,
N Mourali, and
F Tabbane, and
L R Muenz, and
J Behi, and
F Ben Moussa, and
M Jaziri, and
P H Levine
January 1984,
Annales de medecine interne,
N Mourali, and
F Tabbane, and
L R Muenz, and
J Behi, and
F Ben Moussa, and
M Jaziri, and
P H Levine
January 2022,
Harefuah,
N Mourali, and
F Tabbane, and
L R Muenz, and
J Behi, and
F Ben Moussa, and
M Jaziri, and
P H Levine
January 1992,
Frontiers of radiation therapy and oncology,
N Mourali, and
F Tabbane, and
L R Muenz, and
J Behi, and
F Ben Moussa, and
M Jaziri, and
P H Levine
December 2017,
Urology,
